NA Semax Amidate (N-Acetyl Semax Amidate) record · updated 18h ago
NA Semax Amidate is a modified heptapeptide analog of Semax (ACTH 4-10 fragment) studied for cognitive enhancement, neuroprotection, and BDNF/NGF modulation in preclinical research.
How it works: ACTH(4–10) analog; neuroprotective / nootropic
Development stage
where NA Semax Amidate (N-Acetyl Semax Amidate) sits between preclinical work and regulatory approval- 1CurrentPreclinicalAnimal / in-vitro work
- 2Not reachedPhase 1Safety in humans
- 3Not reachedPhase 2Efficacy signal
- 4Not reachedPhase 3Confirmatory trials
- 5Not reachedApprovedCleared by a regulator
Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.
Mass and formula from PubChem CID 172638603. The chain length is only shown where the residues account for that mass, so a figure here has been checked against it rather than taken on trust.
What people are saying
anecdotal · not evidenceUnverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching NA Semax Amidate (N-Acetyl Semax Amidate) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.